helped several drugs achieve market approval|Deepa Pakianathan,General Partner,Delphi Ventures 00:10:00

Share On Facebook Share On Twitter

Deepa is a Managing Member at Delphi Ventures and leads all of the firm’s biotechnology investment activities.She currently serves on the boards of Alder Biopharmaceuticals (Nasdaq:ALDR), Calithera Biosciences (Nasdaq: CALA), ForSight:Vision5, Karyopharm Therapeutics (Nasdaq:KPTI) and Oncomed Pharmaceuticals (Nasdaq:OMED).

Recent Videos